How nerve and blood vessel interactions cause neuropathic spontaneous pain

Neuron vasculature interactions in pain

NIH-funded research University of Cincinnati · NIH-11187154

This work looks at how nerve cells and nearby blood vessels interact to cause spontaneous nerve pain after injury, with the goal of helping people who have neuropathic pain.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati NIH-funded
Lab location1 site (Cincinnati, United States)
Project IDNIH-11187154 on NIH RePORTER

What this research studies

Researchers will use genetically modified mice whose sensory nerve cells light up when active so they can watch nerve activity inside the dorsal root ganglia after nerve injury. They have found clusters of nerve cells that fire on their own after injury and that these cluster firings link to spontaneous pain behaviors in mice. The team will test how activation of the sympathetic nervous system and adrenergic signaling (the body's fight-or-flight chemicals) change these cluster patterns and whether blocking those signals stops the abnormal firing. They will work to determine whether the key targets are the sensory neurons themselves or nearby blood vessels in the ganglia, which could point to different treatment strategies.

Who could benefit from this research

Good fit: People with neuropathic pain from nerve injury who experience ongoing spontaneous pain (not only pain from touch or movement) would be the most relevant group for future trials or related clinical efforts.

Not a fit: People whose pain is purely musculoskeletal, inflammatory, or centrally driven (not due to peripheral nerve injury) are less likely to benefit from the findings.

Why it matters

Potential benefit: If successful, this work could point to new treatment targets — for example drugs that block adrenergic signaling or modify nerve–blood vessel interactions — to reduce hard-to-treat spontaneous neuropathic pain.

How similar studies have performed: Prior mouse work by collaborating labs has shown clustered DRG neuron activity links to spontaneous pain and can be reduced by adrenergic blockers, but human evidence and clinical translation remain limited.

Where this research is happening

Cincinnati, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.